Product
LY3938577
2 clinical trials
3 indications
Indication
HealthyIndication
Type 1 Diabetes MellitusIndication
Type 2 Diabetes MellitusClinical trial
A Three-Part, Randomized, Double-Blind (Part A) and Open-Label (Part B and Part C), Multi-Dose, Phase 1 Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Intravenous LY3938577 in Healthy Participants and Participants With Type 1 Diabetes MellitusStatus: Not yet recruiting, Estimated PCD: 2025-02-17
Clinical trial
A Single and Multiple-Ascending Dose Phase 1 Study to Assess the Safety, Tolerability, and Pharmacokinetics of LY3938577 in Healthy Participants and Participants With Type 2 Diabetes MellitusStatus: Recruiting, Estimated PCD: 2024-08-01